title: Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug.
authors: Benoit
authors: B
authors: Bensaid
authors: Aurore
authors: A
authors: Rozieres
authors: Audrey
authors: A
authors: Nosbaum
authors: Jean-François
authors: JF
authors: Nicolas
authors: Frédéric
authors: F
authors: Berard
mesh_terms: D000328:Adult; D000583:Amikacin / Q000008:administration & dosage / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001170:Arthritis, Infectious / Q000188:drug therapy*; D002478:Cells, Cultured; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D058501:Enzyme-Linked Immunospot Assay; D004802:Eosinophilia / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D007371:Interferon-gamma / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D012882:Skin Tests; D013577:Syndrome; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
chemical_list: D000900:Anti-Bacterial Agents; D007371:Interferon-gamma; D000583:Amikacin